Physician

Aditi Chhada, M.D.

According to 2025 Medicare claims, Aditi Chhada, M.D. (NPI: 1043415342) practices gastroenterology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is GASTROENTEROLOGY ASSOCIATES OF NEW JERSEY, LLC (NPI: 1497932271; TIN: 261443978) and primary practice location at 07661-1931. Chhada is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Chhada's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 266 traditional Medicare patients, billed 969 HCPCS/CPT codes, and received $83,878 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 688 prescription claims across 178 beneficiaries totaling $758,385 in drug costs, led by Stelara (Ustekinumab). DME data shows 11 claims. Open Payments data shows 134 records totaling $1,720. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $243,599 to $758,385. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	253	526	$68,098
2016	218	481	$54,316
2017	178	355	$35,657
2018	190	432	$44,161
2019	170	354	$39,843
2020	136	277	$29,178
2021	248	511	$51,339
2022	254	776	$64,452
2023	244	739	$63,799
2024	266	969	$83,878

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	138	598	$243,599
2016	154	565	$148,110
2017	130	418	$119,883
2018	134	410	$117,186
2019	115	382	$90,098
2020	135	438	$119,641
2021	130	470	$138,827
2022	138	518	$179,265
2023	161	693	$676,072
2024	178	688	$758,385

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$2,366

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	38	39	$231
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	80	105	$105
45380	Biopsy of large bowel using a flexible endoscope	57	57	$102
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	51	53	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	111	157	$81

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	13	728	$352,847
Ocaliva	Obeticholic Acid	14	420	$128,473
Creon	Lipase/Protease/Amylase	29	1,019	$75,344
Xifaxan	Rifaximin	14	372	$46,770
Ibsrela	Tenapanor Hcl	23	750	$42,815

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4153	Enteral formula, nutritionally complete, hydrolyzed proteins (amino acids and peptide chain), includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$2,366

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	134	$1,720	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aditi Chhada, M.D.?

Tedicare shows public-source Medicare data for Aditi Chhada, M.D. (NPI 1043415342), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aditi Chhada, M.D. have ACO affiliation data?

Aditi Chhada, M.D. is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Aditi Chhada, M.D.?

Aditi Chhada, M.D. is linked to GASTROENTEROLOGY ASSOCIATES OF NEW JERSEY, LLC (billing NPI 1497932271) in the available physician profile data.

Does Aditi Chhada, M.D. have Open Payments data?

Aditi Chhada, M.D. has 134 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.